Rocket Pharmaceuticals (RCKT) PT Raised to $80 at Piper Sandler to Reflect The Danon Opportunity
Tweet Send to a Friend
Piper Sandler analyst Tyler Van Buren raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $80.00 (from $60.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
